The altered expression of the prolactin receptor (PRLR) has been associated with the development of various types of cancer, particularly breast, prostate and endometrial cancer. However, in laryngeal tumors, the expression of PRLR has not yet been documented. The aim of this study was to determine the expression and localization of PRLR in laryngeal cancer (LC) in comparison with recurrent respiratory papillomatosis (RRP). PRLR expression was analyzed in 48 paraffin-embedded tissues (18 RRP and 30 laryngeal cancer tissues) by immunoperoxidase staining. Furthermore, PRLR expression was evaluated in ten samples from each group by Western blot analysis and quantitative real-time PCR. PRLR was observed in all laryngeal tumors at different inte...
Background: Primary hyperparathyroidism (PHPT) is an endocrine disorder most commonly affecting wome...
Head and neck squamous cell carcinomas (HNSCC) are a diverse group of tumor types, including neoplas...
Prolactin receptor (PRLR), a type-1 cytokine receptor, is overexpressed in a number of cancer types....
The altered expression of the prolactin receptor (PRLR) has been associated with the development of ...
Prolactin receptor (PRLR) overexpression could play a role in tumorigenesis. The aim of this study w...
Prolactin receptor (PRLR) overexpression could play a role in tumorigenesis. The aim of this study w...
The altered expression of prolactin (PRL) and its receptor (PRLR) has been implicated in breast and ...
Ovarian cancer (OC) is characterized by a high morbidity and mortality, highlighting a great need fo...
Prolactin (PRL) is a hormone produced by the pituitary gland and multiple non-pituitary sites, vital...
Background: The altered expression of prolactin (PRL) and its receptor (PRLR) has been implicated in...
The role of prolactin (PRL) and its receptors in the initiation and development of benign breast tum...
Prolactinomas are the most frequent type of pituitary tumors, which represent 10–20% of all intracra...
Normal development and differentiation of the mammary gland are profoundly influenced by prolactin (...
The role of prolactin (PRL) and its receptors in the initiation and development of benign breast tum...
Abstract The pituitary hormone prolactin (PRL) has been implicated in tumourigenesis. Expression of ...
Background: Primary hyperparathyroidism (PHPT) is an endocrine disorder most commonly affecting wome...
Head and neck squamous cell carcinomas (HNSCC) are a diverse group of tumor types, including neoplas...
Prolactin receptor (PRLR), a type-1 cytokine receptor, is overexpressed in a number of cancer types....
The altered expression of the prolactin receptor (PRLR) has been associated with the development of ...
Prolactin receptor (PRLR) overexpression could play a role in tumorigenesis. The aim of this study w...
Prolactin receptor (PRLR) overexpression could play a role in tumorigenesis. The aim of this study w...
The altered expression of prolactin (PRL) and its receptor (PRLR) has been implicated in breast and ...
Ovarian cancer (OC) is characterized by a high morbidity and mortality, highlighting a great need fo...
Prolactin (PRL) is a hormone produced by the pituitary gland and multiple non-pituitary sites, vital...
Background: The altered expression of prolactin (PRL) and its receptor (PRLR) has been implicated in...
The role of prolactin (PRL) and its receptors in the initiation and development of benign breast tum...
Prolactinomas are the most frequent type of pituitary tumors, which represent 10–20% of all intracra...
Normal development and differentiation of the mammary gland are profoundly influenced by prolactin (...
The role of prolactin (PRL) and its receptors in the initiation and development of benign breast tum...
Abstract The pituitary hormone prolactin (PRL) has been implicated in tumourigenesis. Expression of ...
Background: Primary hyperparathyroidism (PHPT) is an endocrine disorder most commonly affecting wome...
Head and neck squamous cell carcinomas (HNSCC) are a diverse group of tumor types, including neoplas...
Prolactin receptor (PRLR), a type-1 cytokine receptor, is overexpressed in a number of cancer types....